Are risk factors for sudden death in myocardial infarction patients treated with percutaneous coronary intervention different? Analysis of the PAMI database Bohuslav Finta, Howard Frumin, Judy Boura, Gregg W. Stone, Bruce R. Brody, David A. Cox, Eulogio Garcia, Lori L. Grines, Kimberly A. Skelding, Cindy L. Grines. William Beaumont Hospital, Royal Oak, MIJournal of the American College of Cardiology2001PDF9.3 MB
The effects of tirofiban versus abciximab among diabetic patients undergoing stent placement: The TARGET trial David J. Moliterno, Howard C. Herrmann, Eric R. Powers, Cindy L. Grines, Steven J. Yakubov, David J. Cohen, H. Graham Parker, Martin J. Frey, Gregg W. Stone, Eric J. Topol, for the TARGET Investigators. Cleveland Clinic Foundation, Cleveland, OHJournal of the American College of Cardiology2001PDF9.3 MB
Cost-effectiveness of abciximab and stenting in acute myocardial infarction: Results from the CADILLAC trial David J. Cohen, Cindy Grines, David Cox, Thomas Stuckey, John Carroll, John Griffin, Roberta S. Cosgrove, Louise Githiora, Ronna H. Berezin, James Tcheng, Gregg Stone, CADILLAC Investigators. Beth Israel Deaconess Medical Center, Boston, MA, Cardiovascular Data Analysis Center, Boston, MAJournal of the American College of Cardiology2001PDF15 MB
Creatinine clearance but not serum creatinine on admission predicts early and late death after primary angioplasty Simon R. Dixon, Cindy L. Grines, David A. Cox, Gregg W. Stone, Eulogio Garcia, Luiz A. Mattos, Bruce R. Brodie, Alessandro Giambartolomei, Lorelie L. Grines, Judith A. Boura, William W. O'Neill, Marie-Claude Morice. William Beaumont Hospital, Royal Oak, MIJournal of the American College of Cardiology2001PDF13 MB
A prospective, multicenter, international randomized trial comparing four reperfusion strategies in acute myocardial infarction: Principal report of the controlled abciximab and device investigation to lower late angioplasty complications (CADILLAC) trial Gregg W. Stone, Cindy L. Grines, David A. Cox, Eulogio Garcia, James E. Tcheng, Thomas Stuckey, John Carroll, Giulio Guagliumi, Barry…Journal of the American College of Cardiology2001PDF13 MB
Abciximab use during percutaneous intervention in patients with acute myocardial infarction improves early and late clinical outcomes: Final results of the CADILLAC trial James E. Tcheng, Mark Effron, Cindy L. Grines, Eulogio Garcia, David Cox, Thomas Stuckey, John Carroll, Giulio Guagliumi, Barry Rutherford, Alexandra J. Lansky, Paolo Esente, John Griffin, Gregg W. Stone. The Cardiovascular…Journal of the American College of Cardiology2001PDF13 MB
Does stenting and glycoprotein IIb/IIIa receptor blockade improve the prognosis of diabetics undergoing primary angioplasty in acute myocardial infarction? The CADILLAC trial Thomas Stuckey, Cindy L. Grines, David A. Cox, Eulogio Garcia, James E. Tcheng, John Carroll, Barry Rutherford, Giulio Guagliumi, Paolo Esente, Alexandra J. Lansky, John Griffin, Gregg W. Stone. The Cardiovascular Research…Journal of the American College of Cardiology2001PDF13 MB
Effect of stent implantation and glycoprotein IIb/IIIa receptor blockade on TIMI flow and mortality after primary PTCA in acute myocardial infarction: Final results of the CADILLAC trial Cindy L. Grines, David A. Cox, James E. Tcheng, Eulogio Garcia, Thomas Stuckey, John Carroll, Giulio Guagliumi, Barry Rutherford, Paolo Esente, Alexandra J. Lansky, John Griffin, Gregg W. Stone. The…Journal of the American College of Cardiology2001PDF13 MB
